Aquaporins in Immune Cells and Inflammation: New Targets for Drug Development

被引:43
|
作者
da Silva, Ines, V [1 ,2 ]
Soveral, Graca [1 ,2 ]
机构
[1] Univ Lisbon, Fac Pharm, Res Inst Med iMed ULisboa, P-1649003 Lisbon, Portugal
[2] Univ Lisbon, Fac Pharm, Dept Pharmaceut Sci & Med, P-1649003 Lisbon, Portugal
关键词
aquaporins; immune cells; immunity; inflammation; inflammatory disease; HYDROGEN-PEROXIDE; WATER CHANNELS; DOWN-REGULATION; EXPERIMENTAL COLITIS; CEREBRAL EDEMA; LUNG INJURY; RAT MODEL; EXPRESSION; ENDOTOXEMIA; TRANSPORT;
D O I
10.3390/ijms22041845
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The mammalian immune system senses foreign antigens by mechanisms that involve the interplay of various kinds of immune cells, culminating in inflammation resolution and tissue clearance. The ability of the immune cells to communicate (via chemokines) and to shift shape for migration, phagocytosis or antigen uptake is mainly supported by critical proteins such as aquaporins (AQPs) that regulate water fluid homeostasis and volume changes. AQPs are protein channels that facilitate water and small uncharged molecules' (such as glycerol or hydrogen peroxide) diffusion through membranes. A number of AQP isoforms were found upregulated in inflammatory conditions and are considered essential for the migration and survival of immune cells. The present review updates information on AQPs' involvement in immunity and inflammatory processes, highlighting their role as crucial players and promising targets for drug discovery.
引用
收藏
页码:1 / 16
页数:15
相关论文
共 50 条
  • [41] Autophagic pathways as new targets for cancer drug development
    Bo Liu
    Yan Cheng
    Qian Liu
    Jin-ku Bao
    Jin-Ming Yang
    Acta Pharmacologica Sinica, 2010, 31 : 1154 - 1164
  • [42] Leishmania PROTEASES: NEW TARGETS FOR RATIONAL DRUG DEVELOPMENT
    da Silva-Lopez, Raquel Elisa
    QUIMICA NOVA, 2010, 33 (07): : 1541 - 1548
  • [43] Autophagic pathways as new targets for cancer drug development
    Liu, Bo
    Cheng, Yan
    Liu, Qian
    Bao, Jin-ku
    Yang, Jin-Ming
    ACTA PHARMACOLOGICA SINICA, 2010, 31 (09) : 1154 - 1164
  • [44] Drug Development in Dermatology: New Targets for Old Diseases?
    Borroni, Riccardo G.
    CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2012, 13 (10) : 1859 - 1860
  • [45] Adenosine receptors as promising therapeutic targets for drug development in chronic airway inflammation
    Polosa, Riccardo
    Holgate, Stephen T.
    CURRENT DRUG TARGETS, 2006, 7 (06) : 699 - 706
  • [46] New era for mucosal mast cells: their roles in inflammation, allergic immune responses and adjuvant development
    Yosuke Kurashima
    Hiroshi Kiyono
    Experimental & Molecular Medicine, 2014, 46 : e83 - e83
  • [47] New era for mucosal mast cells: their roles in inflammation, allergic immune responses and adjuvant development
    Kurashima, Yosuke
    Kiyono, Hiroshi
    EXPERIMENTAL AND MOLECULAR MEDICINE, 2014, 46 : e83 - e83
  • [48] Spotlight on new anti-inflammatory drug targets in the immune system
    Ward, SG
    O'Neill, LA
    CURRENT OPINION IN PHARMACOLOGY, 2003, 3 (04) : 391 - 395
  • [49] Functional regulators of pancreatic β-cells as possible targets for drug development
    Ishikawa, Tomohisa
    Kaneko, Yukiko
    Nakayama, Koichi
    YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 2007, 127 : 31 - 35
  • [50] New drug targets in inflammation: efforts to expand the anti-inflammatory armoury
    Ward, S. G.
    BRITISH JOURNAL OF PHARMACOLOGY, 2008, 153 : S5 - S6